Honoring Salvador Luria, longtime MIT professor and founding director of the MIT Center for Cancer Research
Koch Institute event celebrates the new MIT Press biography “Salvador Luria: An Immigrant Biologist in Cold War America.”
Koch Institute event celebrates the new MIT Press biography “Salvador Luria: An Immigrant Biologist in Cold War America.”
A new technique for studying liver cells within an organism could shed light on the genes required for regeneration.
J-WAFS Fellows discuss their inspiration for pursuing challenges in water and food systems.
By analyzing enzyme activity at the organism, tissue, and cellular scales, new sensors could provide new tools to clinicians and cancer researchers.
Using biological, chemical, and engineering tools, she has developed strategies to attack molecules once thought to be “undruggable.”
At luncheon, Vice President for Research Maria Zuber and others express appreciation for the Institute’s postdoctoral researchers; new postdoc mentoring award debuts.
Awards support high-risk, high-impact research from early-career investigators.
A capsule that tunnels through mucus in the GI tract could be used to orally administer large protein drugs such as insulin.
Hynes and two other scientists will share the prize for their discoveries of proteins critical for cellular adhesion.
“We can’t think of the brain only as neurons,” says PhD student Mitch Murdock, who explores the cellular basis of Alzheimer’s disease.
A new model that maps developmental pathways to tumor cells may unlock the identity of cancers of unknown primary.
Separating densely packed molecules before imaging allows them to become visible for the first time.
The computational structural biology researcher continues to serve the department and the MIT life sciences community.
The paper test measures the level of neutralizing antibodies in a blood sample and could help people decide what protections they should take against infection.
The findings of a large-scale screen could help researchers design nanoparticles that target specific types of cancer.